Generics 20

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Stavudine manufacturers

20 products found

Filters

20 products found

stavudine + lamivudine

Tablets for oral solution 30 mg + 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19828

This fully integrated transnational pharmaceutical company focuses on developing high-quality formulations to address unmet medical needs. They boast a strong presence in the Indian market and expanding global reach, offering both branded and generic medications, as well as APIs. Their state-of-the-art WHO-GMP certified production facility in Mehsana is equipped to manufacture a wide range of dosage forms, including tablets, capsules, liquids, creams, ointments, and injectables. The company prioritizes innovation, with a pipeline of new products targeting areas like opioid addiction treatment. Key therapy areas include antibacterials, anti-infectives, anti-diarrheals, pain management, anemia management, and opioid de-addiction. They hold product patents and adhere to stringent regulatory guidelines from authorities like the USFDA, EDQM, MHRA, and MCA. Their products are distributed across various regions, including the EU and North America.

lamivudine + nevirapine + stavudine

Tablets for oral solution 150 mg + 200 mg + 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19828

This fully integrated transnational pharmaceutical company focuses on developing high-quality formulations to address unmet medical needs. They boast a strong presence in the Indian market and expanding global reach, offering both branded and generic medications, as well as APIs. Their state-of-the-art WHO-GMP certified production facility in Mehsana is equipped to manufacture a wide range of dosage forms, including tablets, capsules, liquids, creams, ointments, and injectables. The company prioritizes innovation, with a pipeline of new products targeting areas like opioid addiction treatment. Key therapy areas include antibacterials, anti-infectives, anti-diarrheals, pain management, anemia management, and opioid de-addiction. They hold product patents and adhere to stringent regulatory guidelines from authorities like the USFDA, EDQM, MHRA, and MCA. Their products are distributed across various regions, including the EU and North America.

stavudine + lamivudine + nevirapine

Tablets 40 mg + 150 mg + 200 mg, 30 mg + 150 mg + 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #31070

This pharmaceutical company is a leading global player with over 35 years of experience, operating in more than 60 countries across diverse regions. They specialize in manufacturing a wide range of pharmaceuticals, including prescription medications, over-the-counter drugs, and critical care products. Their extensive portfolio boasts over 350 marketed formulations and 1000+ product registrations, spanning numerous therapeutic areas like oncology, infectious diseases, cardiovascular health, and pain management. The company holds WHO GMP & ISO 9001:2015 certifications, reflecting their commitment to quality and regulatory compliance. Their state-of-the-art manufacturing facility in India utilizes cutting-edge technology and employs a highly skilled workforce dedicated to delivering affordable, high-quality products.

Manufacturer usually replies in 84 days

Want to see all 20 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.